Dublin, Jan. 09, 2017 -- Research and Markets has announced the addition of the "Global Markets for Oleochemical Fatty Acids" report to their offering.
The Global Market for Natural Fatty Acids Should Reach $16.2 Billion by 2021 from $12.4 Billion in 2016 at a CAGR of 5.6%, from 2016 to 2021
This report provides an understanding of how the composition of various fats and oils transform into the range, quality and types of acids produced and the applications for which those acids can be used. It explores the various attributes of different acid types and how these cuts compete with synthetic formed products from the petrochemical route and the major applications outlets.
Oleochemicals, such as fatty acids, will be a vital link in the supply chain as their outstanding functionality and versatility make them ideal to be used in a multitude of applications. In addition, the high reactivity of this acid enables the production of a range of derivatives that can be tailored to meet the needs of a number of end-user industries, which use the formulations to produce the ideal blend of functionality and performance.
The range of derivatives is dependent on the reaction site used. Derivatives can be produced using the acid functionality, such as saponification, esterification, ethoxylation or amination, while derivatives based on the unsaturation include isomerization, dimerization, epoxidation and hydrogenation acids.
Fatty acids and their derivatives have a range of functionality that can be used to support the move away from the petrochemical-based platform that is reliant on the rapidly reducing fossil fuel industry since all the easy oil has been extracted and the remaining oil is more inaccessible, more remote and located in more inhospitable environments. While the equivalent renewable biorefinery-type platform has a long way to go to be commercially viable and suitable to replace the petrochemical platform, oleochemicals will be a major contributor to such development.
The study is divided into a number of sections and covers the following fatty acid types:
- Stearic acid.
- Distilled fatty acids.
- Fractionated fatty acids.
- Polyunsaturated acids, including tall oil fatty acids.
- Oleic acids.
Key Topics Covered:
1: Introduction
2: Summary
3: Overview Of The Industry
4: Overview Of Markets And Applications For Natural Fatty Acids
5: Legislation
6: Technology And Chemistry Of Fatty Acids
7: Patents And New Technology Trends In Fatty Acid Technology
8: Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/jtdhx9/global_markets
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Chemicals


McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Bank of America's $72.5M Epstein Settlement: What You Need to Know
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Apple Turns 50: From Garage Startup to AI Crossroads
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal 



